Bridge Bio Eyes Faster Pipeline Progress Through New Funds, Model
This article was originally published in PharmAsia News
Executive Summary
A Series A funding for South Korean bioventure Bridge Biotherapeutics may encourage creation of “no research, development only” bioventures and early investments in the biotech sector.